Freakmode Series FOCUS FREAK
Natural health product licensed in Canada
- Licence holder
- SAGA Sciences Canada, Inc.
- NPN or DIN-HM
- 80088199
- Status
- Active licence
- Licence date
- 5 September 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : N-acétyl L-chlorhydrate de carnitine | 62.5 milligramme | Not calculated |
| Panax ginseng Source : Racine | 25 milligramme | Not calculated |
| 1,3,7-triméthylxanthine Source : Coffea canephora - Graine | 51 milligramme | Not calculated |
| Phosphatidylsérine Source : Lécithine de soja enrichie en phosphatidylsérine | 25 milligramme | Not calculated |
| Astragalus membranaceus Source : Racine | 75 milligramme | Not calculated |
| L-Tyrosine Source : L-Tyrosine | 62.5 milligramme | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 1,500 milligramme Potency : 6 % Terpene lactones | 30 milligramme | Not calculated |
| Bacopa monnieri Source : Sommité Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 1,500 milligramme Potency : 50 % Bacosides | 75 milligramme | Not calculated |
| Eleutherococcus senticosus Source : Racine | 25 milligramme | Not calculated |
| Sceletium tortuosum Source : Feuille et tige Extract : Matériel brut sec Extraction ratio : 2:1 Dry plant equivalent : 25 milligramme Potency : 0.4 % Total alkaloids | 12.5 milligramme | Not calculated |
| Panax quinquefolius Source : Racine | 25 milligramme | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 24 % Flavonoid glycosides | Not specified | Not calculated |
Non-medicinal ingredients
Hypromellose, Dioxyde de silicium, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 day |
Uses authorised in Canada
- Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance - Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance - Used (temporarily) as a mild diuretic - Helps support cognitive function in adults
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking lithium Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome) Consult a health care practitioner prior to use if you have an auto-immune disorder Consult a health care practitioner prior to use if you are taking medications for diabetes, high blood pressure, or seizures If you are taking blood thinners, or digoxin, consult a health care practitioner prior to use Consult a health care practitioner prior to use if you have any type of acute infection Consult a health care practitioner if symptoms persist or worsen. Consult your health care practitioner prior to use if you are taking anxiolytics, MAO inhibitors, antidepressant medications (e.g. selective serotonin reuptake inhibitors (SSRI)), or phosphodiesterase type 4 (PDE4) inhibitors.
- Contre-indications
Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding. Do not use if you have high blood pressure. Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended Do not use if you are pregnant or breastfeeding This product is not intended as a substitute for sleep
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, in which case, discontinue use. Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use. May cause digestive problems
Source
Official Health Canada record, licence 80088199
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.